SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is facing significant volatility and investor scrutiny following the announcement of a multi-billion dollar equity offering to fund a massive backlog of AI-driven server orders. While some in the community view the capital raise as a necessary step to support aggressive growth and meet soaring demand, others are expressing concern over the dilution's impact on shareholders and the company's broader financial health.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is facing significant investor volatility as strong earnings and a massive backlog are being overshadowed by plans for a major capital raise and increased AI infrastructure spending. While the community remains divided between those viewing the company's aggressive capacity expansion as a long-term goldmine and those concerned about dilution and debt, the stock continues to see intense action from both buyers looking to capitalize on recent pullbacks and traders wary of broader sector headwinds.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is experiencing significant market interest driven by an ongoing AI-driven infrastructure supercycle, with investors closely watching for an anticipated major contract announcement in Kentucky. Community sentiment remains largely bullish, focusing on the company's power-heavy strategy and institutional price target upgrades, even as day-to-day price volatility and short-selling activity spark heated debates among shareholders.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is seeing intense community debate as the asset struggles to maintain its safe-haven status amid a broader market correction and falling below its 200-day moving average. Investors are actively discussing the impact of rising bond yields and geopolitical uncertainty, with many split between viewing the recent price drop as an overextended sell-off opportunity or a sign of deeper structural weakness in the gold market.

Tidal Trust II - Defiance Daily Target 2x Long SMCI ETF

Defiance Daily Target 2X Long SMCI ETF

SMCX is experiencing significant volatility driven by the legal challenges and export compliance issues surrounding SMCI, leading to heavy trading volume and speculation regarding potential delisting or further reverse splits. The community remains deeply divided, with some investors aggressively buying the dip in anticipation of a short squeeze or recovery, while others express frustration over decay and losses, warning against holding this leveraged ETF for the long term.

T1 Energy, Inc. engages in providing energy solutions focused on solar module and solar cell manufacturing. It focuses on building an integrated U.S. supply chain for solar and batteries. The company was founded by Tom Einar Jensen, Peter Matrai, and Tore Ivar Slettemoen on August 31, 2023 and is headquartered in Austin, TX.

T1 Energy Inc.

T1 Energy is experiencing heightened volatility and intense social media discussion as traders track its consolidation phase following a massive surge, with bulls aggressively defending key support levels despite ongoing short seller interest and macroeconomic headwinds. The conversation is heavily focused on the company's strategic acquisition of KORE Power to enter the battery storage and AI data center infrastructure markets, which community members view as a pivotal catalyst for long-term growth.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. is trending as investors react to the company's volatile stock performance alongside inflammatory rhetoric from Donald Trump regarding inflation and ongoing Middle East conflicts. The community is sharply divided, with bearish voices highlighting a steady downward trend and broader economic concerns, while supporters remain engaged with the platform's political narrative despite the company's fiscal headwinds.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Market participants are reacting to escalating geopolitical tensions in the Middle East alongside conflicting reports regarding potential diplomatic breakthroughs. Trading sentiment remains highly volatile, with the community closely tracking overnight price action and rhetoric as traders navigate the uncertainty surrounding upcoming economic data and policy decisions.

Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is attracting significant market interest as it balances rapid revenue growth from its core IBSRELA franchise with ongoing institutional speculation regarding potential M&A activity and the impact of the ongoing CMS litigation. Investors are closely monitoring the company's path toward sustained profitability while actively discussing the strategic implications of recent institutional positioning and the potential for a favorable shift in regulatory tailwinds.

ProShares Trust - ProShares UltraPro Short QQQ -3x Shares

ProShares UltraPro Short QQQ

SQQQ is trending as traders attempt to hedge against record-setting tech sector valuations and AI-driven market optimism. The community remains deeply divided, with many actively debating the viability of inverse leveraged funds amid signs of potential volatility, parabolic price action, and recurring geopolitical uncertainties.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

RedHill's Opaganib Receives FDA Rare Pediatric Disease Designation for Neuroblastoma in Addition to Current Orphan Drug Designation

RedHill's Opaganib Receives FDA Rare Pediatric Disease Designation for Neuroblastoma in Addition to Current Orphan Drug Designation RedHill's Opaganib Receives FDA Rare Pediatric Disease Designation for Neuroblastoma in Addition to Current Orphan Drug Designation PR Newswire RALEIGH, N.C. and...

RedHill Launches Enforcement of $11 Million New York Supreme Court Final Judgment Against Kukbo

RedHill Launches Enforcement of $11 Million New York Supreme Court Final Judgment Against Kukbo RedHill Launches Enforcement of $11 Million New York Supreme Court Final Judgment Against Kukbo PR Newswire RALEIGH, N.C. and TEL-AVIV, Israel, June 8, 2026 RALEIGH, N.C.and TEL-AVIV, Israel, June 8...

RedHill Biopharma Advancing Opaganib Options for Novel Dual Host Directed and Direct Acting Antiviral Approach for Ebola Outbreak Biodefense Platforms

RedHill Biopharma Advancing Opaganib Options for Novel Dual Host Directed and Direct Acting Antiviral Approach for Ebola Outbreak Biodefense Platforms RedHill Biopharma Advancing Opaganib Options for Novel Dual Host Directed and Direct Acting Antiviral Approach for Ebola Outbreak Biodefense...

RedHill's RHB-204 Demonstrates Comparable MAP Killing Efficacy to RHB-104 - Important Step in RHB-204 Development for MAP-related Crohn's Disease

RedHill's RHB-204 Demonstrates Comparable MAP Killing Efficacy to RHB-104 - Important Step in RHB-204 Development for MAP-related Crohn's Disease RedHill's RHB-204 Demonstrates Comparable MAP Killing...

RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational Highlights

RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational Highlights RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational Highlights PR Newswire TEL AVIV...

RedHill's Opaganib Enhances Efficacy of Neuroblastoma Chemo Combination and Augment Anti-Tumor Immunity in Triple-Negative Breast Cancer in Preclinical Studies - New Data Presented at AACR 2026

RedHill's Opaganib Enhances Efficacy of Neuroblastoma Chemo Combination and Augment Anti-Tumor Immunity in Triple-Negative Breast Cancer in Preclinical Studies - New Data Presented at AACR 2026 RedHill's Opaganib Enhances Efficacy of Neuroblastoma Chemo Combination and Augment Anti-Tumor Immunity...

H. pylori Infections Market in the 6MM to Observe Stupendous Growth at a CAGR of 9.5% During the Forecast Period (2026-2036)  DelveInsight

H. pylori Infections Market in the 6MM to Observe Stupendous Growth at a CAGR of 9.5% During the Forecast Period (2026-2036) | DelveInsight H. pylori Infections Market in the 6MM to Observe...

Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034)  DelveInsight

Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight Biliary Tract Cancer Market is Predicted to Exhibit...

Joint U.S. Commercialization of RedHill's Talicia Commences

Joint U.S. Commercialization of RedHill's Talicia Commences Joint U.S. Commercialization of RedHill's Talicia Commences PR Newswire RALEIGH, N.C. and TEL-AVIV, Israel, Feb. 25, 2026 The full sales...

What's Going On With Redhill Biopharma Stock On Tuesday?

RedHill Biopharma shares fell after a sharp rally as investors took profits, following updates on its GI drug aimed at easing GLP-1 treatment side effects and potential FDA approval paths.read more...

RedHill Biopharma Ltd. engages in the development and commercialization of drugs for gastrointestinal (GI), infectious diseases, and oncology. The firm's products include Talicia, Movantik, and Aemcolo. It operates through the Commercial Operations and Research and Development segments. The Commercial Operations segment covers areas relating to commercial sales through a subsidiary in the United States. The Research and Development segment includes the study and licensing of therapeutic candidates. The company was founded by Dror Ben-Asher and Ori Shilo on August 3, 2009 and is headquartered in Tel Aviv, Israel.

Current Price	$0.88
Prev Close	$0.8001
Open	$0.80
Dividend Yield	0.00%
50-Day Moving Average	$0.9378
Beta	0.95
Avg. Volume	104,081.90
PE Ratio	-0.01

52-Week High	$3.31
52-Week Low	$0.7101
Market Capitalization	$4.57M
EPS (Annual)	-$0.1008
Price to Book	-0.46
Revenue Per Employee	$22,174.54

RDHLRedHill Biopharma Ltd.

Fundamentals

Feed

News

Sentiment

Fundamentals

Info

Latest RDHL News